For research use only. Not for therapeutic Use.
ABT-724(CAT: I000900) is a potent and selective dopamine D4 receptor agonist, widely utilized in neuropharmacological research. By targeting D4 receptors, ABT-724 modulates dopaminergic signaling, offering insights into its role in neuropsychiatric and cognitive functions. It has been studied for potential applications in treating conditions such as schizophrenia, attention deficit hyperactivity disorder (ADHD), and erectile dysfunction. ABT-724 is a valuable tool for exploring dopamine receptor pharmacology, receptor-ligand interactions, and the development of targeted therapies for central nervous system disorders. Its high specificity and efficacy make it a reliable choice for preclinical research and drug discovery.
| Catalog Number | I000900 |
| CAS Number | 70006-24-5 |
| Synonyms | ABT-724; ABT 724; ABT724; UNII-4WV2575JWT;;1H-Benzimidazole, 2-((4-(2-pyridinyl)-1-piperazinyl)methyl)- |
| Molecular Formula | C17H19N5 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4°Cfor short term (days to weeks), or -20 °C for long term (months). |
| Related CAS | 587870-77-7(trihydrochloride) |
| IUPAC Name | 2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-benzimidazole |
| InChI | InChI=1S/C17H19N5/c1-2-6-15-14(5-1)19-16(20-15)13-21-9-11-22(12-10-21)17-7-3-4-8-18-17/h1-8H,9-13H2,(H,19,20) |
| InChIKey | FRPJGTNLZNXQEX-UHFFFAOYSA-N |
| SMILES | C1CN(CCN1CC2=NC3=CC=CC=C3N2)C4=CC=CC=N4 |
